Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer

This publication has 21 references indexed in Scilit:

• HER2 and Choice of Adjuvant Chemotherapy for Invasive Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15
  JNCI Journal of the National Cancer Institute, 2000
• Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study1
  Journal of the American College of Surgeons, 2000
• Loss of Tumor Marker-Immunostaining Intensity on Stored Paraffin Slides of Breast Cancer
  JNCI Journal of the National Cancer Institute, 1996
• Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast Cancers
  JNCI Journal of the National Cancer Institute, 1992
• Production and Characterization of Murine mAbs to the Extracellular Domain of Human Neu Oncogene Product GP185^HER2
  Hybridoma, 1992
• Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancer
  International Journal of Cancer, 1991
• Prognostic significance of her‐2/neu expression in breast cancer and its relationship to other prognostic factors
  International Journal of Cancer, 1991
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• The influence of protease digestion and duration of fixation on the immunostaining of keratins. A comparison of formalin and ethanol fixation.
  Journal of Histochemistry & Cytochemistry, 1986